Why the study?
Does indapamide or chlorthalidone reduce reperfusion-induced ventricular fibrillation in isolated guinea pig hearts?
Does indapamide or chlorthalidone reduce reperfusion-induced ventricular fibrillation in isolated guinea pig hearts?
Indapamide, but not chlorthalidone, significantly reduces the duration of reperfusion-induced ventricular fibrillation in isolated guinea pig hearts, suggesting that selective IKs blockade may be antiarrhythmic.
Answers are grounded in this paper and cite their sources.
Indapamide shortens reperfusion VF in this model; leaves open whether selective IKs blockade is antiarrhythmic in vivo or clinically.
The delayed rectifier potassium current (IK) is a major repolarizing current in guinea pig ventricular myocytes. Blockade of IK or other repolarizing currents is of increasing interest for development of antiarrhythmic drugs; however, these interventions may also be proarrhythmic. In the present study, we compared the potential antiarrhythmic properties of indapamide and chlorthalidone, two structurally related sulfonamide diuretics which differ in their ability to block the slow component of the delayed rectifier (IKs) in isolated, buffer-perfused guinea pig hearts. Hearts underwent 30-min global no-flow ischemia and 10-min reperfusion. Dose-response (10(-7)-10(-4) M) effects of indapamide or chlorthalidone on reperfusion-induced arrhythmias, coronary flow, and heart rate (HR) were evaluated in a randomized blinded fashion. There was no significant difference in the incidence of ventricular fibrillation (VF) for either compound as compared with untreated controls. However, VF duration was reduced to < 40 s in all hearts treated with indapamide 10(-4) M). Mean VF duration with indapamide 10(-4) M was 31 +/- 4 versus 70 +/- 40 s in controls (p < 0.05). Chlorthalidone did not protect against reperfusion-induced arrhythmias. HR was unchanged with either compound; coronary flow during the control perfusion period increased approximately 43% with indapamide 10(-4) M (p < 0.05 vs. all treatment groups). These results demonstrate that indapamide, but not chlorthalidone, confers significant protection against reperfusion-induced VF in this experimental preparation and suggest that selective block of IKs may be antiarrhythmic.
No takes yet. Share an insight, caveat, or question.
TURGEON et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: